SpineSmith hires new vice-president of R&D
This article was originally published in Clinica
In a bid to strengthen its position in adult stem cell technologies, SpineSmith Partners has appointed Brian Burkinshaw vice-president of R&D. Mr Burkinshaw has over 30 years' experience, both with traditional orthopaedic companies and emerging biologic firms, which SpineSmith believes will help it develop regenerative medicine products. He has previously worked for Spinal Restoration, LDR Spine and Zimmer, as well as venture capital firm Path4 Ventures. SpineSmith (Austin, Texas), along with its subsidiary Celling Technologies, plans to launch two new regenerative products "in the coming months". SpineSmith develops implants and biologics for surgical fixation, correction and regeneration of the spine, while Celling is focused on autologous adult stem cell therapies.